Literature DB >> 17337085

Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer.

Peter Gresner1, Jolanta Gromadzinska, Wojciech Wasowicz.   

Abstract

Available data indicate that there are significant differences in individual susceptibility to lung cancer within the human population. It is believed to be underlie by inherited genetic predispositions related to the genetic polymorphism of several enzymes involved in the detoxification and xenobiotic metabolism. In this review, we collect and discuss the evidence reported up to date on the association between lung cancer and genetic polymorphism of cytochromes P450, N-acetyltransferase, glutathione S-transferases, microsomal epoxide hydrolase, NAD(P)H:quinone oxidoreductase, myeloperoxidase and glutathione peroxidase. All these genes might appear to be candidates for lung cancer susceptibility genes, nevertheless, the present state of the art still offers only a limited explanation of the link between such polymorphisms and increased risk of lung cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17337085     DOI: 10.1016/j.lungcan.2007.02.002

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  13 in total

1.  The case-only independence assumption: associations between genetic polymorphisms and smoking among controls in two population-based studies.

Authors:  M Elizabeth Hodgson; Andrew F Olshan; Kari E North; Charles L Poole; Donglin Zeng; Chiu-Kit Tse; Tope O Keku; Joseph Galanko; Robert Sandler; Robert C Millikan
Journal:  Int J Mol Epidemiol Genet       Date:  2012-11-15

Review 2.  Lung cancer in women.

Authors:  Raúl Barrera-Rodriguez; Jorge Morales-Fuentes
Journal:  Lung Cancer (Auckl)       Date:  2012-12-15

3.  Glutathione S-transferase copy number variation alters lung gene expression.

Authors:  M W Butler; N R Hackett; J Salit; Y Strulovici-Barel; L Omberg; J Mezey; R G Crystal
Journal:  Eur Respir J       Date:  2011-02-24       Impact factor: 16.671

4.  HapMap-based study on the association between MPO and GSTP1 gene polymorphisms and lung cancer susceptibility in Chinese Han population.

Authors:  Jun-dong Gu; Feng Hua; Chao-rong Mei; De-jie Zheng; Guo-fan Wang; Qing-hua Zhou
Journal:  Acta Pharmacol Sin       Date:  2014-05       Impact factor: 6.150

Review 5.  Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities.

Authors:  Edith Lubos; Joseph Loscalzo; Diane E Handy
Journal:  Antioxid Redox Signal       Date:  2011-04-10       Impact factor: 8.401

6.  Polymorphisms of NRF2 gene correlated with decreased FEV1 in lung cancers of smokers.

Authors:  Hidefumi Sasaki; Ayumi Suzuki; Masayuki Shitara; Yu Hikosaka; Katsuhiro Okuda; Satoru Moriyama; Motoki Yano; Yoshitaka Fujii
Journal:  Biomed Rep       Date:  2013-03-19

7.  Association between the polymorphism of three genes involved in the methylation and efflux of arsenic (As3MT, MRP1, and P-gp) with lung cancer in a Mexican cohort.

Authors:  Rogelio Recio-Vega; Sandra Hernandez-Gonzalez; Gladis Michel-Ramirez; Edgar Olivas-Calderón; R Clark Lantz; A Jay Gandolfi; Mary Kay Amistadi
Journal:  J Appl Toxicol       Date:  2020-12-19       Impact factor: 3.628

8.  Transcriptome profiles of carcinoma-in-situ and invasive non-small cell lung cancer as revealed by SAGE.

Authors:  Kim M Lonergan; Raj Chari; Bradley P Coe; Ian M Wilson; Ming-Sound Tsao; Raymond T Ng; Calum Macaulay; Stephen Lam; Wan L Lam
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

9.  Phase I metabolic genes and risk of lung cancer: multiple polymorphisms and mRNA expression.

Authors:  Melissa Rotunno; Kai Yu; Jay H Lubin; Dario Consonni; Angela C Pesatori; Alisa M Goldstein; Lynn R Goldin; Sholom Wacholder; Robert Welch; Laurie Burdette; Stephen J Chanock; Pier Alberto Bertazzi; Margaret A Tucker; Neil E Caporaso; Nilanjan Chatterjee; Andrew W Bergen; Maria Teresa Landi
Journal:  PLoS One       Date:  2009-05-21       Impact factor: 3.240

10.  Polymorphisms in the glutathione pathway modulate cystic fibrosis severity: a cross-sectional study.

Authors:  Fernando Augusto de Lima Marson; Carmen Silvia Bertuzzo; Antonio Fernando Ribeiro; Jose Dirceu Ribeiro
Journal:  BMC Med Genet       Date:  2014-03-04       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.